Stay updated with breaking news from Solid Biosciences Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Solid Biosciences Inc. (NASDAQ:SLDB – Get Rating) was the recipient of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 36,100 shares, a growth of 71.9% from the March 15th total of 21,000 shares. Currently, 0.2% of the company’s stock are sold short. Based […]
MaxCyte Inc on Tuesday said it appointed Douglas Swirsky as its new chief financial officer, effective immediately. The Maryland, US-based cell-engineering focused company said Swirsky previously... | March 28, 2023
ROCKVILLE, Md., March 27, 2023 -- MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization... | March 27, 2023
Research collaboration to target severe form of genetic dilated cardiomyopathyCollaboration strengthens Solid Biosciences’ scientific capabilities and commercial potential in cardiac... | January 11, 2023
05.12.2022 - - Transactions create a precision genetic medicine company focused on neuromuscular and cardiac diseases, led by industry veteran Bo Cumbo - - Company to leverage synergies and key assets, including product candidates for Duchenne muscular ... Seite 1